Jessie Wang

2.7k total citations
59 papers, 1.9k citations indexed

About

Jessie Wang is a scholar working on Cardiology and Cardiovascular Medicine, Ophthalmology and Oncology. According to data from OpenAlex, Jessie Wang has authored 59 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Ophthalmology and 9 papers in Oncology. Recurrent topics in Jessie Wang's work include Atrial Fibrillation Management and Outcomes (16 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Glaucoma and retinal disorders (7 papers). Jessie Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (16 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Glaucoma and retinal disorders (7 papers). Jessie Wang collaborates with scholars based in United States, Germany and Sweden. Jessie Wang's co-authors include Charles Frost, Rebecca A. Boyd, Frank LaCreta, Janice Pursley, Wonkyung Byon, Yu Chen Barrett, Andrew Shenker, Zhigang Yu, Yan Song and Donglu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jessie Wang

56 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessie Wang United States 16 1.4k 888 196 116 109 59 1.9k
Paul A. Reilly United States 13 1.3k 0.9× 864 1.0× 233 1.2× 259 2.2× 81 0.7× 28 1.9k
Maximilian T. Lobmeyer United States 14 1.1k 0.8× 384 0.4× 146 0.7× 231 2.0× 58 0.5× 26 1.6k
Karin Rathgen Germany 10 1.9k 1.3× 1.3k 1.5× 272 1.4× 114 1.0× 69 0.6× 15 2.2k
Isabelle Gouin‐Thibault France 24 1.4k 1.0× 1.1k 1.3× 345 1.8× 186 1.6× 113 1.0× 92 2.2k
Minggao Shi United States 24 2.7k 1.9× 2.0k 2.2× 341 1.7× 256 2.2× 139 1.3× 44 3.3k
Antonio Gómez‐Outes Spain 20 970 0.7× 738 0.8× 233 1.2× 127 1.1× 32 0.3× 47 1.5k
Delphine Brugier France 13 1.1k 0.8× 317 0.4× 570 2.9× 108 0.9× 58 0.5× 35 1.5k
Fabiana Rollini United States 29 2.2k 1.5× 602 0.7× 1.1k 5.8× 75 0.6× 58 0.5× 112 2.5k
Hamim Zahir United States 17 423 0.3× 274 0.3× 200 1.0× 78 0.7× 181 1.7× 52 1.3k
Gianluigi Devoto Italy 9 992 0.7× 675 0.8× 316 1.6× 186 1.6× 37 0.3× 12 1.5k

Countries citing papers authored by Jessie Wang

Since Specialization
Citations

This map shows the geographic impact of Jessie Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessie Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessie Wang more than expected).

Fields of papers citing papers by Jessie Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessie Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessie Wang. The network helps show where Jessie Wang may publish in the future.

Co-authorship network of co-authors of Jessie Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jessie Wang. A scholar is included among the top collaborators of Jessie Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessie Wang. Jessie Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Jodi, Lawrence Baker, Annie Chen, Jessie Wang, & Federico Girosi. (2024). Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer’s Disease‐Modifying Therapies. Alzheimer s & Dementia. 20(S7). 2 indexed citations
3.
Liu, Jodi, Lawrence Baker, Annie Chen, Jessie Wang, & Federico Girosi. (2024). Modeling Early Detection and Geographic Variation in Health System Capacity for Alzheimer's Disease–Modifying Therapies. RAND Corporation eBooks. 1 indexed citations
4.
Wang, Jessie, et al.. (2023). Same-quadrant Baerveldt Glaucoma Implant-250 to Baerveldt Glaucoma Implant-350 exchange. American Journal of Ophthalmology Case Reports. 33. 101975–101975. 1 indexed citations
5.
6.
Wang, Jessie, et al.. (2023). Associations Between Autoimmune Disease and the Development of Age-Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 64(15). 45–45. 5 indexed citations
7.
Wang, Jessie, et al.. (2023). Cyclophotocoagulation in Neovascular Glaucoma with Near-Total Synechial Angle Closure. SHILAP Revista de lepidopterología. 2023. 1–4. 1 indexed citations
8.
Chen, Chongshu, et al.. (2023). Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy. Expert Opinion on Pharmacotherapy. 24(10). 1205–1214. 5 indexed citations
9.
Wang, Jessie, et al.. (2023). The Association of Antibiotic Use and the Odds of a New-Onset ICD Code Diagnosis of Age-Related Macular Degeneration: A Large National Case-Control Study. Investigative Ophthalmology & Visual Science. 64(12). 14–14. 2 indexed citations
10.
Lebwohl, Mark, Ahmed M. Soliman, Hongbo Yang, et al.. (2021). Impact of Risankizumab on PASI90 and DLQI0/1 Duration in Moderate-to-Severe Psoriasis: A Post Hoc Analysis of Four Phase 3 Clinical Trials. Dermatology and Therapy. 12(2). 407–418. 6 indexed citations
11.
Moon, Jee‐Young, et al.. (2021). The Relationship Between Corneal Biomechanics and Intraocular Pressure Dynamics in Patients Undergoing Intravitreal Injection. Journal of Glaucoma. 30(5). 451–458. 3 indexed citations
12.
Frost, Charles, Andrew Shenker, Stanford S. Jhee, et al.. (2018). Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects. Clinical Pharmacology Advances and Applications. Volume 10. 153–163. 13 indexed citations
13.
Barmettler, Anne, Jessie Wang, Moonseong Heo, & Geoffrey J. Gladstone. (2018). Upper Eyelid Blepharoplasty: A Novel Method to Predict and Improve Outcomes. Aesthetic Surgery Journal. 38(11). NP156–NP164. 3 indexed citations
14.
Chang, Ming, Zhigang Yu, Andrew Shenker, et al.. (2015). Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban. The Journal of Clinical Pharmacology. 56(5). 637–645. 131 indexed citations
15.
Frost, Charles, Yan Song, Andrew Shenker, et al.. (2015). Effects of Age and Sex on the Single-Dose Pharmacokinetics and Pharmacodynamics of Apixaban. Clinical Pharmacokinetics. 54(6). 651–662. 75 indexed citations
16.
Frost, Charles, Yan Song, Yu Chen Barrett, et al.. (2014). A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban. Clinical Pharmacology Advances and Applications. 6. 179–179. 97 indexed citations
17.
Wang, Jessie, et al.. (2013). Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects. American Journal of Cardiovascular Drugs. 14(2). 147–154. 121 indexed citations
18.
Frost, Charles, Sunil Nepal, Jessie Wang, et al.. (2013). Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects. British Journal of Clinical Pharmacology. 76(5). 776–786. 225 indexed citations
19.
Frost, Charles, Cui Yi-min, Yan Song, et al.. (2013). Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects. Clinical Pharmacology Advances and Applications. 5. 177–177. 32 indexed citations
20.
Becker, Richard C., Hongqiu Yang, Puneet Mohan, et al.. (2011). Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor. Journal of Thrombosis and Thrombolysis. 32(2). 183–187. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Reilly Breakdown of academic impact, for papers by Maximilian T. Lobmeyer Breakdown of academic impact, for papers by Karin Rathgen Breakdown of academic impact, for papers by Isabelle Gouin‐Thibault Breakdown of academic impact, for papers by Minggao Shi Breakdown of academic impact, for papers by Antonio Gómez‐Outes Breakdown of academic impact, for papers by Delphine Brugier Breakdown of academic impact, for papers by Fabiana Rollini Breakdown of academic impact, for papers by Hamim Zahir Breakdown of academic impact, for papers by Gianluigi Devoto
Rankless by CCL
2026